{"id":"https://openalex.org/W2086902897","doi":"https://doi.org/10.1007/s00210-011-0702-2","title":"Discovery of potential antipsychotic agents possessing pro-cognitive properties","display_name":"Discovery of potential antipsychotic agents possessing pro-cognitive properties","publication_year":2011,"publication_date":"2011-11-14","ids":{"openalex":"https://openalex.org/W2086902897","doi":"https://doi.org/10.1007/s00210-011-0702-2","mag":"2086902897","pmid":"https://pubmed.ncbi.nlm.nih.gov/22083558"},"language":"en","primary_location":{"id":"doi:10.1007/s00210-011-0702-2","doi":"https://doi.org/10.1007/s00210-011-0702-2","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00210-011-0702-2","pdf_url":null,"source":{"id":"https://openalex.org/S159534381","display_name":"Naunyn-Schmiedeberg s Archives of Pharmacology","issn_l":"0028-1298","issn":["0028-1298","0340-5249","1432-1912"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Naunyn-Schmiedeberg's Archives of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005645056","display_name":"Jelveh Lameh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125377440","display_name":"Acadia Pharmaceuticals (United States)","ror":"https://ror.org/030bhbq32","country_code":"US","type":"company","lineage":["https://openalex.org/I125377440"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jelveh Lameh","raw_affiliation_strings":["ACADIA Pharmaceuticals, Inc, San Diego, CA 92121, USA. jelameh@yahoo.com","ACADIA Pharmaceuticals, Inc, San Diego, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ACADIA Pharmaceuticals, Inc, San Diego, CA 92121, USA. jelameh@yahoo.com","institution_ids":["https://openalex.org/I125377440"]},{"raw_affiliation_string":"ACADIA Pharmaceuticals, Inc, San Diego, USA","institution_ids":["https://openalex.org/I125377440"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012594959","display_name":"Krista McFarland","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125377440","display_name":"Acadia Pharmaceuticals (United States)","ror":"https://ror.org/030bhbq32","country_code":"US","type":"company","lineage":["https://openalex.org/I125377440"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Krista McFarland","raw_affiliation_strings":["ACADIA Pharmaceuticals, Inc, San Diego, CA, 92121, USA","ACADIA Pharmaceuticals, Inc, San Diego, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ACADIA Pharmaceuticals, Inc, San Diego, CA, 92121, USA","institution_ids":["https://openalex.org/I125377440"]},{"raw_affiliation_string":"ACADIA Pharmaceuticals, Inc, San Diego, USA","institution_ids":["https://openalex.org/I125377440"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074816633","display_name":"J\u00f6rgen Ohlsson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125377440","display_name":"Acadia Pharmaceuticals (United States)","ror":"https://ror.org/030bhbq32","country_code":"US","type":"company","lineage":["https://openalex.org/I125377440"]},{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE","US"],"is_corresponding":false,"raw_author_name":"Jorgen Ohlsson","raw_affiliation_strings":["ACADIA Pharmaceuticals, Inc, San Diego, CA, 92121, USA","ACADIA Pharmaceuticals, Inc, San Diego, USA","AstraZeneca PLC, Sodertalje, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ACADIA Pharmaceuticals, Inc, San Diego, CA, 92121, USA","institution_ids":["https://openalex.org/I125377440"]},{"raw_affiliation_string":"ACADIA Pharmaceuticals, Inc, San Diego, USA","institution_ids":["https://openalex.org/I125377440"]},{"raw_affiliation_string":"AstraZeneca PLC, Sodertalje, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063477204","display_name":"Fredrik Ek","orcid":"https://orcid.org/0000-0002-5651-8445","observed_orcids":["https://orcid.org/0000-0002-5651-8445"]},"institutions":[{"id":"https://openalex.org/I125377440","display_name":"Acadia Pharmaceuticals (United States)","ror":"https://ror.org/030bhbq32","country_code":"US","type":"company","lineage":["https://openalex.org/I125377440"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fredrik Ek","raw_affiliation_strings":["ACADIA Pharmaceuticals, Inc, San Diego, CA, 92121, USA","ACADIA Pharmaceuticals, Inc, San Diego, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ACADIA Pharmaceuticals, Inc, San Diego, CA, 92121, USA","institution_ids":["https://openalex.org/I125377440"]},{"raw_affiliation_string":"ACADIA Pharmaceuticals, Inc, San Diego, USA","institution_ids":["https://openalex.org/I125377440"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076918693","display_name":"Fabrice Piu","orcid":"https://orcid.org/0000-0001-7733-6598","observed_orcids":["https://orcid.org/0000-0001-7733-6598"]},"institutions":[{"id":"https://openalex.org/I125377440","display_name":"Acadia Pharmaceuticals (United States)","ror":"https://ror.org/030bhbq32","country_code":"US","type":"company","lineage":["https://openalex.org/I125377440"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fabrice Piu","raw_affiliation_strings":["ACADIA Pharmaceuticals, Inc, San Diego, CA, 92121, USA","ACADIA Pharmaceuticals, Inc, San Diego, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ACADIA Pharmaceuticals, Inc, San Diego, CA, 92121, USA","institution_ids":["https://openalex.org/I125377440"]},{"raw_affiliation_string":"ACADIA Pharmaceuticals, Inc, San Diego, USA","institution_ids":["https://openalex.org/I125377440"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053279288","display_name":"Ethan S. Burstein","orcid":"https://orcid.org/0000-0003-1120-9099","observed_orcids":["https://orcid.org/0000-0003-1120-9099"]},"institutions":[{"id":"https://openalex.org/I125377440","display_name":"Acadia Pharmaceuticals (United States)","ror":"https://ror.org/030bhbq32","country_code":"US","type":"company","lineage":["https://openalex.org/I125377440"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ethan S. Burstein","raw_affiliation_strings":["ACADIA Pharmaceuticals, Inc, San Diego, CA, 92121, USA","ACADIA Pharmaceuticals, Inc, San Diego, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ACADIA Pharmaceuticals, Inc, San Diego, CA, 92121, USA","institution_ids":["https://openalex.org/I125377440"]},{"raw_affiliation_string":"ACADIA Pharmaceuticals, Inc, San Diego, USA","institution_ids":["https://openalex.org/I125377440"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103858024","display_name":"Ali Tabatabaei","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125377440","display_name":"Acadia Pharmaceuticals (United States)","ror":"https://ror.org/030bhbq32","country_code":"US","type":"company","lineage":["https://openalex.org/I125377440"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ali Tabatabaei","raw_affiliation_strings":["ACADIA Pharmaceuticals, Inc, San Diego, CA, 92121, USA","ACADIA Pharmaceuticals, Inc, San Diego, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ACADIA Pharmaceuticals, Inc, San Diego, CA, 92121, USA","institution_ids":["https://openalex.org/I125377440"]},{"raw_affiliation_string":"ACADIA Pharmaceuticals, Inc, San Diego, USA","institution_ids":["https://openalex.org/I125377440"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020206371","display_name":"Roger Olsson","orcid":"https://orcid.org/0000-0002-7107-3472","observed_orcids":["https://orcid.org/0000-0002-7107-3472"]},"institutions":[{"id":"https://openalex.org/I125377440","display_name":"Acadia Pharmaceuticals (United States)","ror":"https://ror.org/030bhbq32","country_code":"US","type":"company","lineage":["https://openalex.org/I125377440"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roger Olsson","raw_affiliation_strings":["ACADIA Pharmaceuticals, Inc, San Diego, CA, 92121, USA","ACADIA Pharmaceuticals, Inc, San Diego, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ACADIA Pharmaceuticals, Inc, San Diego, CA, 92121, USA","institution_ids":["https://openalex.org/I125377440"]},{"raw_affiliation_string":"ACADIA Pharmaceuticals, Inc, San Diego, USA","institution_ids":["https://openalex.org/I125377440"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040662134","display_name":"Stefania Risso Bradley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125377440","display_name":"Acadia Pharmaceuticals (United States)","ror":"https://ror.org/030bhbq32","country_code":"US","type":"company","lineage":["https://openalex.org/I125377440"]},{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stefania Risso Bradley","raw_affiliation_strings":["ACADIA Pharmaceuticals, Inc, San Diego, CA, 92121, USA","ACADIA Pharmaceuticals, Inc, San Diego, USA","Merck, WestPoint, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ACADIA Pharmaceuticals, Inc, San Diego, CA, 92121, USA","institution_ids":["https://openalex.org/I125377440"]},{"raw_affiliation_string":"ACADIA Pharmaceuticals, Inc, San Diego, USA","institution_ids":["https://openalex.org/I125377440"]},{"raw_affiliation_string":"Merck, WestPoint, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070529034","display_name":"Douglas W. Bonhaus","orcid":"https://orcid.org/0000-0002-6567-2348","observed_orcids":["https://orcid.org/0000-0002-6567-2348"]},"institutions":[{"id":"https://openalex.org/I125377440","display_name":"Acadia Pharmaceuticals (United States)","ror":"https://ror.org/030bhbq32","country_code":"US","type":"company","lineage":["https://openalex.org/I125377440"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Douglas W. Bonhaus","raw_affiliation_strings":["ACADIA Pharmaceuticals, Inc, San Diego, CA, 92121, USA","ACADIA Pharmaceuticals, Inc, San Diego, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ACADIA Pharmaceuticals, Inc, San Diego, CA, 92121, USA","institution_ids":["https://openalex.org/I125377440"]},{"raw_affiliation_string":"ACADIA Pharmaceuticals, Inc, San Diego, USA","institution_ids":["https://openalex.org/I125377440"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5005645056"],"corresponding_institution_ids":["https://openalex.org/I125377440"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":0.8752,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.75408338,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"385","issue":"3","first_page":"313","last_page":"323"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9854000210762024,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9854000210762024,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.00930000003427267,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.9190000295639038},{"id":"https://openalex.org/keywords/procognitive-effects","display_name":"procognitive effects","score":0.7239999771118164},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.925000011920929},{"id":"https://openalex.org/keywords/cognitive-impairment","display_name":"cognitive impairment","score":0.9860000014305115},{"id":"https://openalex.org/keywords/dopamine-d2-receptor-antagonism","display_name":"dopamine D2 receptor antagonism","score":0.9440000057220459},{"id":"https://openalex.org/keywords/novel-object-recognition","display_name":"novel object recognition","score":0.9210000038146973},{"id":"https://openalex.org/keywords/locomotor-hyperactivity","display_name":"locomotor hyperactivity","score":0.8330000042915344},{"id":"https://openalex.org/keywords/amphetamine-induced-hyperactivity","display_name":"amphetamine-induced hyperactivity","score":0.9150000214576721}],"concepts":[{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.8017361164093018},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5502030849456787},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.5382274389266968},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.5272659063339233},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4830058813095093},{"id":"https://openalex.org/C2775870346","wikidata":"https://www.wikidata.org/wiki/Q2554162","display_name":"Typical antipsychotic","level":5,"score":0.46679478883743286},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.3912537395954132},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3644525706768036},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.23073062300682068}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003071","descriptor_name":"Cognition","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008862","descriptor_name":"Microsomes, Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008862","descriptor_name":"Microsomes, Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D012702","descriptor_name":"Serotonin Antagonists","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D012702","descriptor_name":"Serotonin Antagonists","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D012702","descriptor_name":"Serotonin Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D021641","descriptor_name":"Recognition, Psychology","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D041681","descriptor_name":"NIH 3T3 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D043643","descriptor_name":"Receptor, Muscarinic M1","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D044402","descriptor_name":"Receptor, Serotonin, 5-HT2A","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057809","descriptor_name":"HEK293 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065127","descriptor_name":"Dopamine D2 Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1007/s00210-011-0702-2","doi":"https://doi.org/10.1007/s00210-011-0702-2","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00210-011-0702-2","pdf_url":null,"source":{"id":"https://openalex.org/S159534381","display_name":"Naunyn-Schmiedeberg s Archives of Pharmacology","issn_l":"0028-1298","issn":["0028-1298","0340-5249","1432-1912"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Naunyn-Schmiedeberg's Archives of Pharmacology","raw_type":"journal-article"},{"id":"pmid:22083558","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22083558","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Naunyn-Schmiedeberg's archives of pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:lup.lub.lu.se:afe7691b-e9d8-4616-b1d1-ae9d879f15c7","doi":null,"is_oa":false,"landing_page_url":"https://lup.lub.lu.se/record/afe7691b-e9d8-4616-b1d1-ae9d879f15c7","pdf_url":null,"source":{"id":"https://openalex.org/S4306400536","display_name":"Lund University Publications (Lund University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I187531555","host_organization_name":"Lund University","host_organization_lineage":["https://openalex.org/I187531555"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Naunyn-Schmiedeberg's Archives of Pharmacology; 385(3), pp 313-323 (2012)","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.979200005531311,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320315029","display_name":"ACADIA Pharmaceuticals","ror":"https://ror.org/030bhbq32"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":51,"referenced_works":["https://openalex.org/W54176584","https://openalex.org/W94735219","https://openalex.org/W149195305","https://openalex.org/W1518922051","https://openalex.org/W1616286551","https://openalex.org/W1822227732","https://openalex.org/W1969181688","https://openalex.org/W1972793472","https://openalex.org/W1984762359","https://openalex.org/W1987593166","https://openalex.org/W1996657079","https://openalex.org/W1999799735","https://openalex.org/W2005714328","https://openalex.org/W2006909079","https://openalex.org/W2011099157","https://openalex.org/W2011926257","https://openalex.org/W2014260646","https://openalex.org/W2016231653","https://openalex.org/W2035601252","https://openalex.org/W2046411639","https://openalex.org/W2047507052","https://openalex.org/W2047757089","https://openalex.org/W2053306852","https://openalex.org/W2053357782","https://openalex.org/W2058413990","https://openalex.org/W2062009247","https://openalex.org/W2066610089","https://openalex.org/W2073988872","https://openalex.org/W2074883322","https://openalex.org/W2076808460","https://openalex.org/W2081792830","https://openalex.org/W2085360366","https://openalex.org/W2092829073","https://openalex.org/W2095457266","https://openalex.org/W2101081940","https://openalex.org/W2108988641","https://openalex.org/W2109865728","https://openalex.org/W2112739763","https://openalex.org/W2116225616","https://openalex.org/W2124452122","https://openalex.org/W2127339766","https://openalex.org/W2136962131","https://openalex.org/W2144091159","https://openalex.org/W2150174494","https://openalex.org/W2159155203","https://openalex.org/W2164973255","https://openalex.org/W2180693160","https://openalex.org/W2345907171","https://openalex.org/W2411934174","https://openalex.org/W2418806785","https://openalex.org/W2503799583"],"related_works":["https://openalex.org/W2996338950","https://openalex.org/W1998581169","https://openalex.org/W2760731060","https://openalex.org/W7221892656","https://openalex.org/W1987249329","https://openalex.org/W4393166724","https://openalex.org/W2609650343","https://openalex.org/W2782416300","https://openalex.org/W2342221550","https://openalex.org/W4398179366"],"abstract_inverted_index":null,"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}